 Comparison tobramycin intervals treatment pulmonary exacerbations cystic fibrosis patients efficacy toxicity shortened tobramycin interval treatment exacerbations Pseudomonas pulmonary infection cystic fibrosis patients Patients years treatment courses pairs tobramycin hours Peak serum concentrations micrograms/ml total daily dosage patients tobramycin hours shorter interval pulmonary function follow-up time next hospital admission pulmonary exacerbation study hospitalization differences pulmonary function tests clinical score sputum carriage aeruginosa toxicity necessary length hospitalization tobramycin interval efficacious dosing interval treatment cystic fibrosis patients